Sentences with phrase «new treatments for human disease»

Richard H. Scheller is Executive Vice President of Research and Early Development at Genentech, where his role is to see basic research translated into the development of new treatments for human disease.

Not exact matches

InvivoSciences will continue to contribute to the improvement of human health by establishing a new paradigm for discovering drugs that focus on diseases with limited treatment options such as cardiac fibrosis, scleroderma, and lupus in a time - effective manner while remaining safe and cost effective.»
Now, a study published online April 27th, in the Journal of Immunology, confirms that the cytokine GM - CSF (Granulocyte macrophage colony - stimulating factor) likely plays an important role in human disease and offers a new explanation for why the MS treatment interferon - Beta (INF - β) is often effective at reducing MS attacks.
Scientists want to be able to clone early human embryos, using cells from patients with various diseases, so they can study the diseases in the lab and develop new treatments for them.
The findings open up new avenues for the treatment of injuries and degenerative diseases in adult humans.
German and Canadian scientists have built a three dimensional map of the human brain to help in the development of new treatments for neurological disorders like Alzheimer's and Parkinson's disease.
Her research is both translational and clinical in nature and centers on the human genetics of healthy skin aging and diseases related to aging skin, including new treatments for advanced basal cell skin cancers.
NIH researchers publish the genomes of 178 microbes that call the human body home — the project could lead to new treatments for disease
From this research published in Scientific Reports, scientists aim to unravel the causes behind the disease in zebrafish and therefore provide new leads for a treatment for human LCA.
Now, in a new study published in the journal Cell, scientists at the Salk Institute for Biological Studies have discovered that a synthetic form of vitamin D, calcipotriol (a drug already approved by the FDA for the treatment of psoriasis), deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential new therapy for fibrotic diseases in humans.
Still, Firestein notes, the results need to be borne out in humans before scientists start investigating new treatments for the disease.
Scientists working to develop new treatments for neurodegenerative diseases have been stymied by the inability to grow human motor neurons in the lab.
Salk researchers found that a drug already approved by the FDA for the treatment of psoriasis deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential new therapy for fibrotic diseases in humans.
These so - called bioreactors, and the mini-brains they foster, should open other new and valuable windows into human brain development, brain disorders and drug testing — and perhaps even produce neurons for treatment of Parkinson's disease and other disorders, the investigators say.
Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease.
Our finding of similarity in clinical progression between human patients and Huntington's disease monkeys suggests monkeys could become a preclinical, large animal model for the development of new treatments
Broad Institute of MIT and Harvard was launched in 2004 to improve human health by using genomics to advance our understanding of the biology and treatment of human disease, and to help lay the groundwork for a new generation of therapies.
The pigs showed both movement problems and respiratory difficulties common to human patients, and it is hoped that this model will assist in the creation of new treatments for Huntington's — a genetically inherited and fatal disease which affects tens of thousands of people.
They have also compared the mouse and human genomes, which together are expected to help researchers find genes for diseases and lead to new treatments for human illness.
The group's objectives are focused on using neural progenies of human Pluripotent Stem (hPS) cells to understand and develop new treatments for Huntington Disease (HD).
These powerful tools are rapidly changing the way researchers do their work, and providing new and novel approaches to treatments for human disease.
This «humanized» mouse is susceptible to human liver infections and responds to human drug treatments, providing a new way to test novel therapies for debilitating human liver diseases and other diseases with liver involvement such as malaria.
Stem cell researchers are getting closer to a new treatment for sickle cell disease, moving promising laboratory research into human clinical trials.
Lanner also hopes to learn things that could help scientists who are trying to turn stem cells from human embryos into new treatments for diseases.
A new stem cell treatment in Australia designed to treat the root cause of Parkinson's disease has received approval for human testing.
Gage and Ghosh discuss how human skin cells induced to return to an immature state («induced pluripotent stem cells» or IPS cells) are revolutionizing our understanding and treatment of mental and neurodegenerative disorders, such as Parkinson's disease, as well as leading to new models of drug development for all diseases.
GENYO is the first national centre devoted to genomics that integrates the Public Administration, the University and the biotechnology and pharmaceutical business sector, which would allow the integration of research in all its phases, from the generation of knowledge to its development in clinical and pharmaceutical applications, the development of new projects and services for the prevention, diagnosis and treatment of diseases associated to human genetic variability, such a cancer and rare diseases, diabetes, hypertension or degenerative diseases, among others.
This new treatment has a long way to go before human trials, but it could one day result in better treatments for the millions of people suffering from heart disease.
Donations made to the TGen Foundation will be used to fund TGen's research needs for improving human health by helping scientists discover new treatments, therapies and cures for many diseases such as autism, melanoma, pancreatic cancer, brain tumors, diabetes and others.
However, every time a pet travels internationally without proper prior veterinary care and treatment, it is another chance for diseases that can impact both human and animal health to establish themselves in a new area.
The findings may help further understanding of neurodegenerative diseases and identify new treatments for both canine and human sufferers.
a b c d e f g h i j k l m n o p q r s t u v w x y z